Name: Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Start: 2025-06-20T08:00:00-05:00
End: 2025-06-20T17:00:00-05:00

October 2024
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

February 10, 2024 - February 10, 2025

February 10, 2024 Take Me to the Event Registration EVENT Summary Dates Saturday, February 10, 2024, 11:00 AM ET, 10:00 AM CT, and 9:00 AM MT Location Virtual Target Audience Neurologists, nurse practitioners, and physician assistants involved in Alzheimer’s disease patient care. Format Zoom Webinar Credits 1.50 / AMA PRA Category 1 Credit(s)TM Cost Free Program…
January 2025
Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures

January 25, 2025

January 25, 2025 Take Me to the Event Registration EVENT Summary Dates Saturday, January 25, 2025, 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT Location Virtual Target Audience Ophthalmologists, optometrists, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with cataracts. Format Zoom Webinar Credits 1.25 / AMA…
March 2025
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation

March 1, 2025

March 8, 2025 Take Me to the Event Registration EVENT Summary Dates Saturday, March 8, 2025, 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT Location Virtual Target Audience Ophthalmologists, optometrists, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with ocular surface disease Format Zoom Webinar Credits…
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation

March 12, 2025 @ 8:00 AM - March 12, 2026 @ 5:00 PM

CME | 1.25 Credits Webcast Time to Complete: 75 minutes Released: March 12, 2025 Expires: March 12, 2026 Maximum Credits: 1.25 / AMA PRA Category 1 CreditsTM Start Activity Program Description This webcast provides…
April 2025
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes

April 12, 2025 @ 8:00 AM - 5:00 PM

Take Me to the Event Registration EVENT Summary Dates Saturday, April 12, 2025, 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT Location Virtual Target Audience Ophthalmologists, optometrists, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with dry eye disease (DED) Format Zoom Webinar Credits 1.25 / AMA…
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes

April 16, 2025 @ 8:00 AM - April 16, 2026 @ 5:00 PM

CME | 1.25 Credits Webcast Time to Complete: 75 minutes Released: April 16, 2025 Expires: April 16, 2026 Maximum Credits: 1.25 / AMA PRA Category 1 CreditsTM Resume Activity Program Description This enduring webcast…
June 2025
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | 1.25 Credits Webcast Time to Complete: 75 minutes Released: March 5, 2025 Expires: March 5, 2026 Maximum Credits: 1.25 / AMA PRA Category 1 CreditsTM Start Activity Program Description This enduring webcast program aims to enhance healthcare professionals' understanding of neurotrophic keratitis (NK). Participants will explore the etiology, pathophysiology, and recommended screening and diagnostic procedures essential for…
Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | 1.25 Credits Webcast Time to Complete: 75 minutes Released: January 28, 2025 Expires: January 28, 2026 Maximum Credits: 1.25 / AMA PRA Category 1 CreditsTM Start Activity Program Description This webcast provides an update on cataract surgery. Cataract surgery is the most commonly performed of all ophthalmic surgeries worldwide, and several exciting innovations continue to provide better…
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes

June 20, 2025 @ 8:00 AM - 5:00 PM

CME 1.50 Credits Webcast Time to Complete: 90 minutes Released: September 5, 2024 Expires: September 5, 2025 Maximum Credits: 1.50 / AMA PRA Category 1 CreditsTM Start Activity Program Description This webcast provides an update on the MGD-DED. Eyelid inflammation, microbial growth, associated skin disorders, and potentially severe corneal complications make MGD a complex multifactorial disorder. MGD is a…
Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | CNE 1.50 Credits Webcast Time to Complete: 90 minutes Released: August 15, 2024 Expires: August 15, 2025 Maximum Credits: 1.50 / AMA PRA Category 1 CreditsTM 1.50 / ANCC Contact Hours Start Activity Program Description This webcast provides an update on the blood-based markers (BBMs) improve randomized clinical trials (RCTs) design and conduct of Alzheimer’s disease. It…

October 2024

New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

January 2025

Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures

March 2025

Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation

Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation

April 2025

Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes

Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes

June 2025

Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis

Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures

MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes

Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

Site Links

Quick Links

Categories